Novel 31-amino-acid-length endothelins cause constriction of vascular smooth muscle

Biochem Biophys Res Commun. 1998 Jul 20;248(2):387-90. doi: 10.1006/bbrc.1998.8980.

Abstract

We have reported that human chymase specifically cleaves big endothelins (ETs) at the Try31-Gly32 bond, and produces novel trachea-constricting 31-amino-acid-length ETs, ETs(1-31). In this study, we investigated the effect of synthetic ETs(1-31) on the contractile activity toward porcine coronary arteries and rat aortae. Although ETs(1-31) exhibited less potent vasoconstrictile activity in these tissues than 21-amino-acid-length ETs(1-21), or a similar extent, ET-1(1-31) caused significantly slower-developing and longer-lasting contraction than ETs(1-21). The ETA receptor antagonist, BQ485, completely inhibited the activity of ET-1(1-31). The ETB receptor antagonist, BQ788, also inhibited the activity of ET-1(1-31) toward rat aortae more efficiently than that ET-1(1-21). Therefore, trachea-constricting peptides ETs(1-31) play roles as vasoconstrictors in a different manner from ETs(1-21).

MeSH terms

  • Animals
  • Arteries / drug effects
  • Azepines / pharmacology
  • Chymases
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Endothelins / pharmacology*
  • Humans
  • Muscle, Smooth, Vascular / drug effects*
  • Oligopeptides / pharmacology
  • Peptide Fragments / pharmacology
  • Piperidines / pharmacology
  • Protein Precursors / pharmacology*
  • Rats
  • Serine Endopeptidases / metabolism*
  • Swine
  • Trachea / drug effects
  • Vasoconstrictor Agents / pharmacology

Substances

  • Azepines
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Endothelins
  • Oligopeptides
  • Peptide Fragments
  • Piperidines
  • Protein Precursors
  • Vasoconstrictor Agents
  • BQ 485
  • BQ 788
  • Serine Endopeptidases
  • Chymases